View all cases
UPC APP 1178/2025
—·EP3831282: REMOTE MONITORING OF ANALYTE MEASUREMENTS
- Case details
- Status—ActionProcedural applicationCategoryWithdrawal Applications
- Parties
- ClaimantsReps: Anne-Charlotte le Bihan (Bird & Bird LLP); Laurent Labatte (Bird & Bird LLP); David Sproston (Hoffmann Eitle); Mark Jones (Hoffmann Eitle)Respondents
- Abbott Laboratories
- Abbott Diabetes Care Inc.
- Abbott France (S.A.S.)
- Abbott (S.A./N.V.)
- Abbott B.V.
- Abbott s.r.l.
- Abbott Scandinavia Aktiebolag
- Abbott Oy
- Abbott Gesellschaft m.b.H.
- Abbott Laboratories A/S
- Abbott GmbH
- Abbott Diagnostics GmbH
- Abbott Logistics B.V.
- Newyu, Inc.
Reps: Christian Dekoninck (Taylor Wessing); François Pochart (August Debouzy); Wim Maas (Taylor Wessing); Eelco Bergsma (Taylor Wessing) - Division
- Court of Appeal
- Judges
- Rian Kalden · Presiding judge and legally qualified judge
- Ingeborg Simonsson · Legally qualified judge and judge-rapporteur
- Patricia Rombach · Legally qualified judge
- Technology
- Healthcare Informatics
- Language
- —
- First decided
- Jan 24, 2025
Decisions
- 2025-01-24WithdrawnApplication Rop 265
Court of Appeal Panel 2 order permitting DexCom's withdrawal of its infringement appeal and declaring the proceedings closed. Background: the Paris Local Division had revoked EP 3 831 282 (continuous glucose monitoring) and dismissed all DexCom infringement claims; DexCom appealed but then applied to withdraw the action including the appeal. The withdrawal was permitted, proceedings closed, and 60% of appeal court fees refunded to DexCom. No costs decision required.
Legal issues:Withdrawal of infringement action and appeal (R. 265 RoP)Reimbursement of court fees (R. 370.9 RoP)Continuous glucose monitoring device patents
Documents
- A6E198E2701ACC50EC4E0B5856C06044_en.pdf2025-01-24ENGLISH